News
PRFX
0.9606
-5.82%
-0.0594
PainReform Initiates Phase II Development for OcuRing™-K
TipRanks · 4d ago
PainReform Launches Phase II Trial Development for OcuRing-K Drop-Less Ocular Therapy
Reuters · 4d ago
PainReform commences development plan for OcuRing-K Phase II trial
TipRanks · 4d ago
PainReform Commences Development Plan For OcuRing-K, LayerBio's Patented, Drop-Less, Intraoperatively Administered Sustained-Release Ocular Therapy
Benzinga · 4d ago
BRIEF-Painreform Commences Development For Ocuring™-K Phase II Trial
Reuters · 4d ago
PainReform Advances Drop-Less OcuRing-K Therapy Toward Phase II Trial
Reuters · 4d ago
PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio’s Drop-Less Sustained-Release Ocular Therapy
Barchart · 4d ago
Weekly Report: what happened at PRFX last week (1124-1128)?
Weekly Report · 5d ago
PainReform Ltd. Announces December 2025 Shareholders Meeting with Key Proposals
TipRanks · 11/25 21:54
PainReform Ltd. Announces Date for Upcoming Annual General Meeting of Shareholders
Reuters · 11/25 21:16
Weekly Report: what happened at PRFX last week (1117-1121)?
Weekly Report · 11/24 09:18
Weekly Report: what happened at PRFX last week (1110-1114)?
Weekly Report · 11/17 09:18
PainReform’s DeepSolar Advances AI Reporting Engine for Solar Assets
TipRanks · 11/12 14:34
PainReform’s DeepSolar advances development of AI-driven reporting engine
TipRanks · 11/12 14:10
DeepSolar Advances AI-Driven Reporting Engine for Solar Asset Analysis
Reuters · 11/12 14:00
Weekly Report: what happened at PRFX last week (1103-1107)?
Weekly Report · 11/10 09:17
PainReform’s DeepSolar Advances with NVIDIA Connect and Pilot Projects
TipRanks · 11/05 14:17
PainReform’s DeepSolar Advances AI Solar Forecasting with NVIDIA Connect Program
Reuters · 11/05 13:31
PAINREFORM’S DEEPSOLAR, DEVELOPING “DEEPSOLAR PREDICT” WITHIN THE NVIDIA CONNECT PROGRAM, FEATURED IN THE MARKET LINK’S “WATCHLIST INTERVIEW” AND ANNOUNCES PROGRESS TOWARD PILOT PROJECTS
Reuters · 11/05 13:30
Weekly Report: what happened at PRFX last week (1027-1031)?
Weekly Report · 11/03 09:17
More
Webull provides a variety of real-time PRFX stock news. You can receive the latest news about Painreform Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PRFX
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.